1 / 12

Norbert Gerbsch, PhD Head of Affairs – Biotechnology / R&D

Gain insights into accessing the lucrative Indian pharmaceutical market from the perspective of an entrepreneur. Explore growth rates, challenges, and opportunities, alongside strategies for market entry. Discover key differences between the Indian and German markets and learn how to overcome obstacles. Leverage the expertise of BPI - The German Pharmaceutical Industry Association for networking and collaboration opportunities. Overcome access barriers by finding local partners and navigating regulatory and cultural challenges.

ayla
Download Presentation

Norbert Gerbsch, PhD Head of Affairs – Biotechnology / R&D

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. India How to Access a Promising Market?Challenges from the Viewpoint of an EntrepreneurInterested to Access the Indian Market Norbert Gerbsch, PhD Head of Affairs – Biotechnology / R&D BPI - German Pharmaceutical Industry Association

  2. Population: 2006: 1.15 bn. 2030: 1.51 bn. a huge market! Growth Rates: 2008: 8.2% Above world average growing income! Drug Sales: Above par for three years growing sales! India – First Sight A Promising Market… Charts from: Deutsche Bank Research: India´s pharmaceutical industry on course for globalisation April 2008, www.dbresearch .com

  3. India – First Sight Chart from: Deutsche Bank Research: India´s pharmaceutical industry on course for globalisation April 2008, www.dbresearch .com …for German Companies!?

  4. India – Second Sight

  5. Consequences India is a huge and promising market, but… compared to Germany: • different volume • different pricing levels • different spending per capita • different structure (directly payed by customer vs. health insurance) • different distribution systems • similar company structure (small to medium sized, privately owned) …more differences than similarities!

  6. Chances / Challenges • for specialty care products, which are not yet available in India • which are patent protected or protected otherwise (production technologies) - Roundabout 20 German companies have established a presence in India • needs very careful analysis of the Indian markets • local partners which know the situation in India • marketing, reimbursement, distribution, authorities,

  7. Market Access - Challenges • to obtain valid information for market evaluation / planning • to obtain sustainable information about government plans to develop the health system – mid to long term • to find partners in India • product protection by patents • Infrastructure • payment transactions • different time frames • high customs for imported goods • cultural challenges

  8. Networking in the German Pharmaceutical IndustryHow to Use an Existing PlatformBPI - The German Pharmaceutical Industry Association - Established in 1951 -

  9. The German Pharmaceutical Industry Association (BPI) • Established in 1951, with 57 years of experience in the development, regulatory approval and marketing of pharmaceuticals as well as political lobbying • An alliance of about 260 members, representing a wide spectrum of the pharmaceutical industry • Small Enterprises • Multinational Corporations • Contract Manufacturers • Contract Research Organizations (CROs) • Attorneys specializing in pharmaceutical law • Consultants • An ideal information and communication platform

  10. The Staff of the BPI • The BPI covers many diverse fields of activities, which can be summarized in sixcentral core competencies: • Medicine and Pharmacy • Biotechnology / R & D • Politics • Law • Self Medication • Press / Public Relations • At BPI, experts from various disciplines work closely together – pharmacists, physicians, economists, lawyers, etc.

  11. Support / BPI Cooperation platform The BPI Cooperation Platformon the BPI homepage offers • Members and • Non-members the opportunity to find business partners in various fields or to actively offer themselves as partners. Offers are posted anonymously, with the BPI acting as a intermediary between the two partners Might be useful to overcome some of the access barriers mentioned

  12. Thank you for your attention! ngerbsch@bpi.de

More Related